Literature DB >> 15206948

Malonyl-CoA decarboxylase (MCD) is differentially regulated in subcellular compartments by 5'AMP-activated protein kinase (AMPK). Studies using H9c2 cells overexpressing MCD and AMPK by adenoviral gene transfer technique.

Nandakumar Sambandam1, Michael Steinmetz, Angel Chu, Judith Y Altarejos, Jason R B Dyck, Gary D Lopaschuk.   

Abstract

Malonyl-CoA, a potent inhibitor of carnitine pamitoyl transferase-I (CPT-I), plays a pivotal role in fuel selection in cardiac muscle. Malonyl-CoA decarboxylase (MCD) catalyzes the degradation of malonyl-CoA, removes a potent allosteric inhibition on CPT-I and thereby increases fatty acid oxidation in the heart. Although MCD has several Ser/Thr phosphorylation sites, whether it is regulated by AMP-activated protein kinase (AMPK) has been controversial. We therefore overexpressed MCD (Ad.MCD) and constitutively active AMPK (Ad.CA-AMPK) in H9c2 cells, using an adenoviral gene delivery approach in order to examine if MCD is regulated by AMPK. Cells infected with Ad.CA-AMPK demonstrated a fourfold increase in AMPK activity as compared with control cells expressing green fluorescent protein (Ad.GFP). MCD activity increased 40- to 50-fold in Ad.MCD + Ad.GFP cells when compared with Ad.GFP control. Co-expressing AMPK with MCD further augmented MCD expression and activity in Ad.MCD + Ad.CA-AMPK cells compared with the Ad.MCD + Ad.GFP control. Subcellular fractionation further revealed that 54.7 kDa isoform of MCD expression was significantly higher in cytosolic fractions of Ad.MCD + Ad.CA-AMPK cells than of the Ad.MCD +Ad.GFP control. However, the MCD activities in cytosolic fractions were not different between the two groups. Interestingly, in the mitochondrial fractions, MCD activity significantly increased in Ad.MCD + Ad.CA-AMPK cells when compared with Ad.MCD + Ad.GFP cells. Using phosphoserine and phosphothreonine antibodies, no phosphorylation of MCD by AMPK was observed. The increase in MCD activity in mitochondria-rich fractions of Ad.MCD + Ad.CA-AMPK cells was accompanied by an increase in the level of the 50.7 kDa isoform of MCD protein in the mitochondria. This differential regulation of MCD expression and activity in the mitochondria by AMPK may potentially regulate malonyl-CoA levels at sites nearby CPT-I on the mitochondria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206948     DOI: 10.1111/j.1432-1033.2004.04218.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Fatty acids stimulate AMP-activated protein kinase and enhance fatty acid oxidation in L6 myotubes.

Authors:  Matthew J Watt; Gregory R Steinberg; Zhi-Ping Chen; Bruce E Kemp; Mark A Febbraio
Journal:  J Physiol       Date:  2006-04-27       Impact factor: 5.182

2.  The Mammalian Malonyl-CoA Synthetase ACSF3 Is Required for Mitochondrial Protein Malonylation and Metabolic Efficiency.

Authors:  Caitlyn E Bowman; Susana Rodriguez; Ebru S Selen Alpergin; Michelle G Acoba; Liang Zhao; Thomas Hartung; Steven M Claypool; Paul A Watkins; Michael J Wolfgang
Journal:  Cell Chem Biol       Date:  2017-05-04       Impact factor: 8.116

3.  SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase.

Authors:  Gaëlle Laurent; Natalie J German; Asish K Saha; Vincent C J de Boer; Michael Davies; Timothy R Koves; Noah Dephoure; Frank Fischer; Gina Boanca; Bhavapriya Vaitheesvaran; Scott B Lovitch; Arlene H Sharpe; Irwin J Kurland; Clemens Steegborn; Steven P Gygi; Deborah M Muoio; Neil B Ruderman; Marcia C Haigis
Journal:  Mol Cell       Date:  2013-06-06       Impact factor: 17.970

4.  Malonyl-CoA mediates leptin hypothalamic control of feeding independent of inhibition of CPT-1a.

Authors:  Su Gao; Wendy Keung; Dolors Serra; Wei Wang; Patricia Carrasco; Nuria Casals; Fausto G Hegardt; Timothy H Moran; Gary D Lopaschuk
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-04-20       Impact factor: 3.619

5.  Acetylation contributes to hypertrophy-caused maturational delay of cardiac energy metabolism.

Authors:  Arata Fukushima; Liyan Zhang; Alda Huqi; Victoria H Lam; Sonia Rawat; Tariq Altamimi; Cory S Wagg; Khushmol K Dhaliwal; Lisa K Hornberger; Paul F Kantor; Ivan M Rebeyka; Gary D Lopaschuk
Journal:  JCI Insight       Date:  2018-05-17

6.  Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy.

Authors:  E Douglas Lewandowski; Susan K Fischer; Matthew Fasano; Natasha H Banke; Lori A Walker; Alda Huqi; Xuerong Wang; Gary D Lopaschuk; J Michael O'Donnell
Journal:  Circ Res       Date:  2012-09-14       Impact factor: 17.367

Review 7.  AMP-activated protein kinase control of fat metabolism in skeletal muscle.

Authors:  D M Thomson; W W Winder
Journal:  Acta Physiol (Oxf)       Date:  2009-02-19       Impact factor: 6.311

Review 8.  Role of the malonyl-CoA synthetase ACSF3 in mitochondrial metabolism.

Authors:  Caitlyn E Bowman; Michael J Wolfgang
Journal:  Adv Biol Regul       Date:  2018-09-05

Review 9.  AMPK: Lessons from transgenic and knockout animals.

Authors:  Benoit Viollet; Yoni Athea; Remi Mounier; Bruno Guigas; Elham Zarrinpashneh; Sandrine Horman; Louise Lantier; Sophie Hebrard; Jocelyne Devin-Leclerc; Christophe Beauloye; Marc Foretz; Fabrizio Andreelli; Renee Ventura-Clapier; Luc Bertrand
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  IKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis.

Authors:  Jia Dai; Di-Fei Shen; Zhou-Yan Bian; Heng Zhou; Hua-Wen Gan; Jing Zong; Wei Deng; Yuan Yuan; FangFang Li; Qing-Qing Wu; Lu Gao; Rui Zhang; Zhen-Guo Ma; Hong-Liang Li; Qi-Zhu Tang
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.